Lucira Health, Inc. (LHDX) Social Stream

Lucira Health, Inc. (LHDX): $5.42

-0.56 (-9.36%)

POWR Rating

Component Grades













Lucira Health Inc (LHDX) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering Lucira Health Inc.

Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
3 $9 $7 $8 $8.05 -0.62%
3 $9 $6.5 $7.75 $8.05 -3.73%
3 $5.5 $5.5 $5.5 $8.05 -31.68%
3 $6.5 $6.5 $6.5 $8.05 -19.25%

The Trend in the Analyst Price Target

LHDX's average price target has moved down $0.5 over the prior 31 weeks.

Over the past 41 weeks, LHDX's average upside potential has been 46.74%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-12-28 3 9 7 8 8.05 -0.62%
2021-03-13 NA 29 29 29 15.19 90.92%

LHDX Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
3.33 0 0 2 0 0 3

The Trend in the Broker Recommendations

LHDX's average broker recommendation rating worsened by 1 over the prior 31 weeks.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for LHDX as an investment opportunity.

  • Lucira Health Inc's upside potential (average analyst target price relative to current price) is higher than 19.98% of all US stocks.
  • LHDX has a greater average analyst price target than 22.56% of all US stocks.
  • In the context of Pharmaceutical Products stocks, Lucira Health Inc's variance in analysts' estimates is lower than 46.44% of them.
  • Lucira Health Inc's number of analysts covering the stock is greater than 55.96% of Pharmaceutical Products stocks.

In the Pharmaceutical Products industry, NVO, CLVS and CORT are the three stocks most similar to Lucira Health Inc regarding the price target and analyst recommendation information presented here.

Is LHDX a Buy, Hold or Sell? See the POWR Ratings now!

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 2.0309 seconds.